Hiromitsu Ohta

914 total citations
39 papers, 647 citations indexed

About

Hiromitsu Ohta is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Hiromitsu Ohta has authored 39 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Hiromitsu Ohta's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Hiromitsu Ohta is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Hiromitsu Ohta collaborates with scholars based in Japan, Canada and Maldives. Hiromitsu Ohta's co-authors include Toshihiro Nukiwa, Masahito Ebina, Shigeki Chiba, Mikio Furuse, Yasumi Ohshima, Takashi Hirose, Takashi Misumi, Shu Hisata, Takashi Kondo and Tsutomu Tamada and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Development.

In The Last Decade

Hiromitsu Ohta

36 papers receiving 632 citations

Peers

Countries citing papers authored by Hiromitsu Ohta

Since Specialization

Citations

This map shows the geographic impact of Hiromitsu Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Ohta more than expected).

Fields of papers citing papers by Hiromitsu Ohta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Ohta. The network helps show where Hiromitsu Ohta may publish in the future.

Co-authorship network of co-authors of Hiromitsu Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromitsu Ohta. A scholar is included among the top collaborators of Hiromitsu Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromitsu Ohta. Hiromitsu Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Lung Cancer Exhibiting Pleoymorphic Carcinoma Transformation Resistance Following Treatment With Osimertinib That Was Successfully Treated Using Local Ablative Treatment 2024 ·Thoracic Cancer ·(unknown), Hiromitsu Ohta, (unknown), (unknown), (unknown), Yuki Maeda, (unknown), (unknown), Yasuhiro Yamaguchi	0
2	First Reported Case of Pure Red Cell Aplasia Related to Sotorasib 2024 ·Internal Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuki Maeda, (unknown), (unknown), (unknown), Hiromitsu Ohta, Yasuhiro Yamaguchi	0
3	miR‐4448/Girdin/Akt/AMPK axis inhibits EZH2‐mediated EMT and tumorigenesis in small‐cell lung cancer 2024 ·Cancer Medicine ·Nobuyuki Koyama, Yuichi Ishikawa, Hiromitsu Ohta, Takuya Aoki, (unknown), Kazutetsu Aoshiba, Kazutsugu Uematsu	3
4	Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report 2023 ·Thoracic Cancer ·(unknown), (unknown), (unknown), (unknown), Yuki Maeda, (unknown), Hiromitsu Ohta, (unknown), Yasuhiro Yamaguchi	1
5	Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed 2023 ·Thoracic Cancer ·Hisao Imai, (unknown), (unknown), Yoshiaki Nagai, (unknown), (unknown), Takashi Osaki, (unknown), Yukihiro Umeda, Akihiro Ono, Hiroyuki Minemura, Yutaka Yamada, Junichi Nakagawa, (unknown), Hirokazu Taniguchi, Hiromitsu Ohta, Takashi Kasai, Kyoichi Kaira, Hiroshi Kagamu	7
6	Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel 2023 ·Oncology ·(unknown), Hisao Imai, Takeshi Tsuda, (unknown), Yoshiaki Nagai, (unknown), (unknown), Akihiro Ono, Yutaka Yamada, (unknown), Takashi Osaki, Junichi Nakagawa, Yukihiro Umeda, Hiroyuki Minemura, (unknown), Hirokazu Taniguchi, Hiromitsu Ohta, Kyoichi Kaira, Hiroshi Kagamu	3
7	Secondary pulmonary hypertension due to pulmonary Langerhans cell histiocytosis accompanied with panhypopituitarism 2020 ·Respirology Case Reports ·(unknown), Susumu Yamazaki, Hiromitsu Ohta, Hidetoshi Nakamura, Makoto Nagata	1
8	OA07.03 Clinical Outcome of Non-Small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertions Identified in the LC-SCRUM-Japan 2019 ·Journal of Thoracic Oncology ·Hibiki Udagawa, Shingo Matsumoto, Yuichiro Ohe, Miyako Satouchi, Naoki Furuya, (unknown), Takashi Seto, Kenzo Soejima, Daisuke Hayakawa, Terufumi Kato, Shingo Miyamoto, Kadoaki Ohashi, Sho Saeki, Hiromitsu Ohta, Daichi Fujimoto, Akimasa Sekine, Kiyotaka Yoh, Keiko Goto	8
9	Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile 2017 ·BMC Pulmonary Medicine ·Masayuki Itô, Kazuyuki Nakagome, Hiromitsu Ohta, Keiichi Akasaka, Yoshitaka Uchida, Atsushi Hashimoto, Ayako Shiono, Toshinori Takada, Makoto Nagata, Jun Tohyama, Koichi Hagiwara, Minoru Kanazawa, Koh Nakata, Ryushi Tazawa	11
10	A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer 2017 ·PLoS ONE ·Yoshiaki Inoue, (unknown), Hitoshi Miyazawa, Hiromitsu Ohta, (unknown), Yoshiaki Nagai, Kunihiko Kobayashi, Yasuo Saijo, Masanori Tsuchida, Mitsuo Nakayama, Koichi Hagiwara	10
11	A young immunocompetent patient with spontaneous Aspergillus empyema who developed severe eosinophilia 2017 ·Respiratory Medicine Case Reports ·(unknown), Hiromitsu Ohta, Yoshiaki Nagai, (unknown), Shinichiro Koyama	4
12	Two Cases ofLegionella pneumophilaPneumonia with Prolonged Neurologic Symptoms and Brain Hypoperfusion on Single-Photon Emission Computed Tomography 2016 ·SHILAP Revista de lepidopterología ·Hiromitsu Ohta, Susumu Yamazaki, (unknown), Akira Seto, Minoru Kanazawa, Makoto Nagata	2
13	Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells 2012 ·PLoS ONE ·Masahiko Kanehira, Toshiaki Kikuchi, Shinya Ohkouchi, (unknown), Naoki Tode, (unknown), (unknown), Hiromitsu Ohta, Tsutomu Tamada, Toshihiro Nukiwa	20
14	The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema 2012 ·Pulmonary Medicine ·Shigeki Chiba, Hiromitsu Ohta, (unknown), Shu Hisata, Shinya Ohkouchi, Yasushi Hoshikawa, Takashi Kondo, Masahito Ebina	20
15	A Case of Cutaneous Infection Caused by Mycobacterium Szulgai with Progression to Acute Respiratory Distress Syndrome 2011 ·SHILAP Revista de lepidopterología ·Hiromitsu Ohta, Eisaku Miyauchi, Masahito Ebina, Toshihiro Nukiwa	7
16	The Disappearance of Subpleural and Interlobular Lymphatics in Idiopathic Pulmonary Fibrosis 2010 ·Lymphatic Research and Biology ·Masahito Ebina, Naoko Shibata, Hiromitsu Ohta, Shu Hisata, Tsutomu Tamada, Masao Ono, (unknown), Takashi Kondo, Toshihiro Nukiwa	35
17	A Normal Range of KL-6/MUC1 Independent of Elevated SP-D Indicates a Better Prognosis in the Patients with Honeycombing on High-Resolution Computed Tomography 2010 ·Pulmonary Medicine ·Shu Hisata, Yuichiro Kimura, Naoko Shibata, Shuichi Ono, Takao Kobayashi, Shigeki Chiba, Hiromitsu Ohta, Toshihiro Nukiwa, Masahito Ebina	16
18	Pirfenidone, A Novel Anti-fibrotic Agent, Provides Higher Benefit For Idiopathic Pulmonary Fibrosis (IPF) Patients With Better Pulmonary Function 2010 ·Masahito Ebina, Yuichiro Kimura, Hiromitsu Ohta, Shu Hisata, Tsutomu Tamada, Toshihiro Nukiwa	2
19	Granulocyte-Macrophage Colony–Stimulating Factor and Lung Immunity in Pulmonary Alveolar Proteinosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Ryushi Tazawa, Emi Hamano, Toru Arai, Hiromitsu Ohta, Osamu Ishimoto, Kanji Uchida, Masato Watanabe, Junichi Saito, (unknown), Yasuhiko Hirabayashi, Ikuo Ishige, Yoshinobu Eishi, Koichi Hagiwara, Masahito Ebina, Yoshikazu Inoue, Koh Nakata, Toshihiro Nukiwa	77
20	Molecular Basis of β-Thalassemia in the Maldives 1998 ·Hemoglobin ·Hiroyasu Furuumi, (unknown), Takuya Inoue, Hiromitsu Ohta, Pranee Winichagoon, Suthat Fucharoen, Yasuyuki Fukumaki	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact